SCHEMBL7786972

SCHEMBL7786972

COc1cc2c(c(OC(=O)Cc3ccccc3)c1OC)=NC(=O)C(=O)N=2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 1/20 0.47
KDM4E B2RXH2 1/20 0.41
HPGD P15428 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALOX5 P09917 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
UCHL1 P09936 1/20 0.38
USP5 P45974 1/20 0.38
USP4 Q13107 1/20 0.38
SENP1 Q9P0U3 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7784292 0.79 GRIN2D (0.48) ALDH1A1MAPTKDM4ECYP3A4ALOX5
SCHEMBL7786675 0.73 GRIN2D (0.65) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL9628298 0.72 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL9628295 0.71 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL9641650 0.70 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL30233793 0.69 L3MBTL1 (0.60) SMN1; SMN2ALDH1A1MAPTHPGDCYP1A2
SCHEMBL1171372 0.69 L3MBTL1 (0.60) SMN1; SMN2ALDH1A1MAPTHPGDCYP1A2
SCHEMBL6150807 0.68 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL8318992 0.66 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1KDM4EHPGDMEN1
SCHEMBL7823257 0.66 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1KDM4EHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed